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Glaucoma is a widely distributed progressive optic neuropathy characterized by 
progressive damage and loss of retinal ganglion cells of the retina and optic nerve, optic 
disc excavation increasing and usually, but not always, high intraocular pressure, which 
eventually results in gradual changes in the visual field.  In our study, we tried to 
determine the potential role and place of electrophysiological researches (PERG and VEP) 
in the early detection of glaucoma optic neuropathy, comparing the electrophysiological 
parameters (P100 and A) and numeric parameters in ophthalmic patients studied. The 
results obtained in our study show that the application of PERG methods detects early 
damage to the retinal ganglion cells, whereas the same changes were not observed by 
VEP analysis, suggesting a potential role of predictive PERG analysis in the early 
diagnosis of pre-perimetric glaucoma. Acta Medica Medianae 2012;51(4):19-25. 
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Introduction 
 
  Glaucoma is a widely distributed progressive 
optic neuropathy characterized by progressive 
damage and loss of retinal ganglion cells of the retina 
and optic nerve, increasing of optic disc excavation 
and usually, but not always, high intraocular pressure, 
which eventually results in gradual changes in the 
visual field (1). There are many types of glaucoma, 
the most common of which is open-angle glaucoma. 
Patients with elevated intraocular pressure without 
optic nerve damage and without visual field changes 
are defined as patients with ocular hypertension and 
they are at risk of developing glaucoma (2,3). At the 
same time, glaucoma is the leading cause of blindness 
worldwide, indicating a potentially significant early 
detection and treatment of this disease (4). 
  Glaucoma as a disease cannot be studied in 
isolation. For a full explanation of glaucoma, its 
etiology, pathogenesis, clinical presentation, and for 
the proper diagnosis and appropriate therapeutic 
approach, it is necessary to associate the studies of 
glaucoma with the following areas of medicine: 
neurology, cardiology (local and general circulation), 
endocrinology (study of diabetes), and geriatrics.  
  Early detection and prevention of glaucoma 
progression is vital in order to initiate or modify the 
medical treatment, and also to prevent permanent 
and total loss of sight in future (5). Diagnostic tests 
which are important in glaucoma must be sensitive 
enough to detect early glaucoma progression and to 
identify those patients with ocular hypertension who 
are at higher risk of developing glaucoma (2,6). 
  Nowadays, clinical researches which should 
elucidate the neurophysiological aspects of the 
pathogenesis of primary open-angle glaucoma are 
rare. In the recent years, the development of various 
neurophysiological techniques that provide the insight 
into the state of the visual system as a whole (7,8) 
have been intensified. In use are: electrooculogram   
(EOG), flash electroretinogram (ERG), pattern 
electroretinogram (PERG), multifocal electroretino-
gram (mfERG), visual evoked potentials (VEP) and 
multifocal evoked potentials (mfVEP) (9-11). 
  These techniques can register early changes in 
the retinal structure and function of the optic nerve, 
which is significant both from a diagnostic and a 
therapeutic point of view (13,14). It has been 
established that the pattern electroretinogram (PERG) 
provides information about the function of the 
ganglion cell layer which is the first to be damaged in 
glaucoma, and visual evoked potentials (VEP) about 
the function of the optic nerve (15-18). In practice, 
we use both neurophysiological techniques together 
because they provide information about the function 
of an anatomical entirety, making it possible to 
monitor the transmission of visual information from 
the retina to the visual cortex in various diseases 
including glaucoma (19,20). 
  Bearing in mind the previous bibliographic data, 
in our study we tried to determine the potential role 
and place of electrophysiological studies (PERG and 
VEP) in the early detection of glaucoma optic 
neuropathy, comparing the electrophysiological para-
meters (P100 and A) and numeric parameters in 
ophthalmic patients studied (21-23). Potential role of visually evoked potential and electroretinography...                                                                 Maja Petrović et al. 
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  Patients and methods 
  
  Clinical examination was carried out on 25 
patients (50 eyes) with primary open-angle 
glaucoma (simplex form), 27 patients (54 eyes) 
with ocular hypertension and 25 patients (50 
eyes) with no ophthalmic and neurological disease 
(control group). All study subjects were completely 
clinically ophthalmologically tested in terms of 
glaucoma (determination of visual acuity, biomicro-
scopy, ophthalmoscopy, daily curve of intraocular 
pressure, gonioscopy, standard automated peri-
metry), after which they were divided into the 
above mentioned test groups. 
  Each subject underwent the electrophysiol-
ogical study (VEP, PERG) as a basic test to 
confirm the diagnosis. The obtained values of 
electrophysiological tests are shown as P100 
wave latency value (VEP analysis) and the value 
of the wave amplitude N95 (PERG analysis). 
  Electrophysiological tests (VEP, PERG) were 
examined with Nihon Kohden apparatus under 
the following technical requirements: 
  VEP: Time base 30 ms, above 100Hz filter, 
the filters below 1Hz, the amplitude of 20 
microvolts, stimulation of "pattern" (chess box), 
box size 32, frequency of 2 c/sec (cycle per 
second). Centered are 100 stimuli. Position of 
electrodes: Active electrode Oz, reference electrode 
at Fz (by 10-20 international system), the earth 
electrode on the vertex. 
  PERG: Time base 30 ms, above 100Hz filter, 
the filters below 1Hz, 5 microvolts amplitude, 
stimulation of the "pattern" (chess box), box size 
32, frequency of 2 c/sec (cycle per second). 
Centered are 100 stimuli. Position of electrodes: 
Active electrode temporal bone, the reference 
electrode is the lower eyelid, the earth electrode 
at the vertex. 
  Tests were carried out at the Department 
of Ophthalmology (Office for glaucoma) and the 
Department of Mental Health (Office for neuro-
physiological tests) at the Clinical Center in Niš. 
  
 Statistical  analysis 
  
  In the analysis, the default error margin of 
0.05 or 5% was used for the limits of statistical 
significance. The comparison of representation of 
certain categories of attribute characteristics 
between groups was done with Mantel-Haenszel 
chi square test. To assess the interdependence 
between the values of some of the features 
correlation analysis was used and the Pearson 
(Pearson) correlation coefficients were calculated. 
 
  Results 
 
  Demographic and clinical characteristics of 
the patients in our study are shown in Table 1. 
 
Table 1. Demographic and clinical characteristics of the studied groups 
 
Group 
Characteristic  Glaucoma 
(n=50) 
Ocular 
hypertension 
(n=54) 
Control 
(n=50) 
SS 
Age  55,60±13,16 52,00±8,67  52,96±9,44  n.s. 
Men  18 (36,0%)  18 (33,3%)  22 (44,0%) 
Women  32 (64,0%)  36 (66,7%)  28 (56,0%) 
n.s. 
DM  6 (12,5%)  2 (3,7%)  6 (12,5%)  n.s. 
HTA  10 (20,0%)  6 (11,1%)  16 (32,0%)  n.s. 
Thyroid disease  6 (12,0%)  2 (3,8%)  2 (4,0%)  n.s. 
Positive family anamnesis  10 (20,0%)  12 (23,1%)   8 (16,0%)  n.s. 
Other   8 (17,4%)  20 (37,0%)   8 (17,4%)  n.s. 
 
SS- statistical significance, DM -diabetes mellitus, HTA-hypertensio arterialis, n.s.- no statistical significance,  
n – total number of subjects in the relevant groups 
 
Table 2. P100 wave latency values in compared groups 
 
Group 
Characteristic  Glaucoma 
(n=50) 
Ocular 
hypertension 
(n=54) 
Control 
(n=50) 
Comparison 
P100 OD (msec)   114,63±2,79  100,79±5,02  97,94±3,92  A‡, B‡, C* 
P100 OD up to 113,4 msec   14 (28,0%)  54 (100,0%)  50 (100,0%) 
P100 OD over 113,4 msec   36 (72,0%)  -  - 
A‡, B‡ 
P100 OS (msec)  114,23±2,55  101,03±4,92  98,27±4,01  A‡, B‡, C* 
P100 OS up to 113,4 msec   22 (44,0%)  54 (100,0%)  50 (100,0%) 
P100 Os over 113,4 msec   28 (56,0%)  -  - 
A‡, B‡ 
 
P100 OD – right eye wave latency value P100, P100 OS – P100 of the left eye,  
A – glaucoma vs ocular hypertension; B – glaucoma vs control group, C – ocular hypertension vs control group, 
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Table  3. Values of the wave amplitude N95 in compared groups 
 
Group 
Characteristic  Glaucoma 
(n=50) 
Ocular 
hypertension 
(n=54) 
Control 
(n=50) 
Comparison 
A OD (microV)  0,26±0,12 1,43±0,63 1,69±0,40  A‡,  B‡ 
A OD over 0,4 microV  -  44 (81,5%)  50 (100,0%) 
A OD up to 0,4 microV  50 (100,0%)  10 (18,5%)  - 
A‡, B‡, C* 
A OS (microV)  0,29±0,13  1,34±0,62  1,66±0,44  A‡, B‡, C* 
A OS over 0,4 microV  -  44 (81,5%)  50 (100,0%) 
A OS up to 0,4 microV  50 (100,0%)  10 (18,5%)  - 
A‡, B‡, C* 
 
A OD – left eye amplitude wave value N95,  A OS – right eye value, A- glaucoma vs ocular hypertension;  
B – glaucoma vs control group, C – ocular hypertension vs control group * -p<0,05; †- p<0,01; 
‡ - p<0,001, n – total number of subjects inthe relevant group 
 
Table 4. Correlation between P100 values and other factors of interest in three groups of subjects 
 
Glaucoma 
(n=50) 
Ocular hypertension 
 (n=54) 
Control 
(n=50)  Characteristic 
r p r p r p 
Age  -0,139  0,334 0,026 0,851  -0,009 0,950 
Visus  -0,029  0,842  - - - - 
IOP (mmHg)  0,262  0,066 -0,037 0,790  0,274  0,054 
MD (dB)  -0,671 <0,001 -0,810 <0,001 -0,944 <0,001 
CPSD  0,689 <0,001 0,528 <0,001 0,257  0,071 
Disease stage  0,777  <0,001  - - - - 
Gonioscopy  0,166 0,249 0,265 0,063 0,125 0,409 
Excavation  0,647 <0,001 0,432  0,001 -0,214  0,135 
A  (microV)  -0,653 <0,001 -0,747 <0,001 -0,779 <0,001 
 
In the group of glaucoma subjects, a significant  positive correlation was found between the P100 and  
CPSD values (r=0,689; p<0,001), disease stage (r=0,777; p<0,001) and excavation (r=0,647; p<0,001),  
while a significant negative correlation was found between the P100 and MD values (r=-0,671; p<0,001),  
as well as A (r=-0,653; p<0,001).  
 
Table 5. Correlation between A values and other factors of interest in three groups of subjects 
 
Glaucoma 
 (n=50) 
Ocular hypertension 
 (n=54) 
Control 
(n=50)  Characteristic 
r p  r  p  r  p 
Age  -0,009 0,952  0,041  0,768  -0,182  0,205 
Visus  0,177 0,219  -  -  -  - 
IOP (mmHg)  -0,357 0,011  -0,111  0,426  0,009  0,953 
MD (dB)  0,812 <0,001  0,854  <0,001  0,837  <0,001 
CPSD  -0,785 <0,001  -0,597  <0,001  -0,368  0,009 
Disease stage  -0,781 <0,001  -  -  -  - 
Gonioscopy  -0,242 0,091  -0,236  0,099  -0,078  0,606 
Excavation  -0,813 <0,001  -0,523  <0,001  0,095  0,514 
 
In the group of glaucoma subjects, a significant  positive correlation was found between the A and MD 
values (r=0,812; p<0,001), while a significant negative correlation was found between the A and CPSD  
values (r=-0,785; p<0,001), disease stage (r=-0,781; p<0,001),  excavation (r=-0,813; p<0,001),  
as well as P100 (r=-0,653; p<0,001).  
 
  As shown in Table 1, the difference in the 
average age of the respondents, by gender, presence 
of DM, hypertension, thyroid disease, family history 
and other major diseases among the samples tested, 
was not statistically significant, indicating uniformity of 
the tested groups. 
  In the further course of the study, we analyzed 
the latencies of P100 and amplitude N95, as the main 
parameters of the electrophysiological methods used 
in our study. The results are shown in Table 2 and 
Table 3. 
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  Based on the results obtained for P100, the 
examinees were categorized into two categories 
(up to 113.4 and over 113.4 msec). The analysis 
of the average value of P100 on the right eye in 
patients with glaucoma showed significantly higher 
values (p<0.001) compared to other groups. The 
value of P100 was detected in patients with 
ocular hypertension, in comparison to the control 
group (p<0.05). Individual representation of 
P100 values in patients with glaucoma showed a 
significant difference (p<0.001) compared to the 
other groups. 
  Further evaluation of the potential electro-
physiological parameters included the detection and 
analysis of the wave amplitude in the N95 PERG 
analysis (IIA). Based on the values obtained for 
A, all the patients were categorized into two 
groups (up to 0.4 microV and over 0.4 microV). 
The results presented in Table 3 show that the 
value of A in patients with glaucoma is 
significantly lower than in other tested groups 
(p<0.001). Evident and statistically significant is 
the difference (p<0.001, p<0.05) in the repre-
sentation of the value of A among all groups 
(0.001). Within the group of patients with ocular 
hypertension 18.5% of persons with a significant 
decrease in the amplitude of the wave N95 PERG 
were detected, which was not detected in the 
same group of subjects, using the P100 value 
analysis.  
  Taking into account the results obtained for 
P100 and A, we have tried to use a correlation in 
order to determine if there was any correlation 
between the electrophysiological methods tested 
in the examined parameters of the subjects. The 
results are shown in Table 4 and Table 5. 
  In the group of patients with ocular hyper-
tension, a significant positive correlation was 
confirmed between P100 and CPSD values 
(r=0.528, p<0.001), as well as the excavation 
(r=0.432, p=0.001), whereas a significant negative 
correlation between the values  MD P100 (r=-0.810, 
p<0.001), and A (r=-0.747, p<0.001) was confirmed. 
  In the control group, a significant correlation 
between P100 and other factors of interest was not 
confirmed.  
  In the group of patients with glaucoma, a 
significant positive correlation was confirmed between 
the values of A and MD (r=0.812, p<0.001), whereas 
a significant negative correlation was confirmed 
between the values of A and IOP (r=-0.357, 
p<0.05), CPSD (r=-0.785, p<0.001), disease stage 
(r=-0.781, p<0.001) and excavation (r=-0.813, 
p<0.001). 
  In the group of patients with ocular hyper-
tension, a significant positive correlation was 
confirmed between the values of A and MD 
(r=0.854, p<0.001), whereas a significant negative 
correlation was confirmed between the values of 
A and CPSD (r=-0.597, p<0.001), and excavation 
(r=-0.523, p<0.001). In the control group, no 
significant correlations between the certified 
values and other factors of interest were 
confirmed. 
  Discussion 
  
  Pathogenetic mechanisms responsible for 
the damage and loss of retinal ganglion cells 
(RGC) in glaucoma are still not fully interpreted. 
Damage to these cells is often attributed to high 
intraocular pressure (IOP), which exists in most 
patients – The Mechanical theory of origin of 
glaucoma (24). However, evidence from studies 
with low-tension glaucoma and ocular hyper-
tension indicate that elevated IOP is not sufficient 
to explain the glaucomatous optic neuropathy. 
Therefore, other risk factors such as vascular and 
hemorrheological dysfunction and metabolic 
disorders stand are emphasized – The Vascular 
theory of glaucoma occurrence (25,26). Recent 
histological studies of the retina in experimental 
glaucoma and in patients with glaucoma have 
indicated that retinal nerve cells suffer damage 
by apoptosis-like mechanism - The Excitotoxic 
theory of origin of glaucoma (4,27).  
  The tests in our study included subjects 
diagnosed with glaucoma, patients with ocular 
hypertension and the control group. Based on 
analysis of demographic and clinical characte-
ristics of the patients included in our study, it is 
evident that there is no significant difference in 
the evaluated characteristics between the tested 
groups, suggesting uniformity and proper selection 
of patients in our study. 
  Results of the VEP analysis showed an 
increase of P100 latency in patients with 
glaucoma compared to other groups. Positive 
correlation in patients with glaucoma was found 
between P100 and CPSD values, stage of disease 
and excavation, while a negative correlation 
between the values MD P100 and A was 
confirmed. In individuals with ocular hyper-
tension, a positive correlation between the value 
of P100 and CPSP and stage of disease was 
confirmed, while a significant negative correlation 
between the values MD and P100 and A values 
was confirmed. The data point to significant 
increases in P100 latency in patients with 
glaucoma, compared to the other study groups, 
which is consistent with previous studies (28-30), 
indicating a change in functional status of optic 
nerve fibers, as well as the overall visual pathway 
postretinally located, probably as a result of 
dysfunction of the retinal structure (30,22). 
Unlike patients with glaucoma, in individuals with 
ocular hypertension, prolonged P100 above the 
physiologic range was not detected. Our data are 
consistent with the findings which have shown 
that there was no significant difference between 
the control group and those with ocular 
hypertension, with the value of VEP (31). 
However, in earlier studies, a prolonged P100 in 
patients with ocular hypertension (32,33) was 
noticed, indicating that functional impairment 
may precede excavation changes as well as 
visual field defects (30). Discrepancies in the 
results are most likely resulting from different 
patient selection. In fact, previous studies Acta Medica Medianae 2012, Vol.51(4)                                     Potential role of visually evoked potential and electroretinography... 
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included both patients with early glaucoma in the 
group of patients with ocular hypertension 
(32,33), which may result in conflicting results 
obtained. 
  PERG analysis in our study showed a 
significantly reduced value of the wave amplitude 
N95 in patients with glaucoma, compared to all 
groups. However, the analysis of the PERG of 
patients with ocular hypertension showed that in 
18.5% of respondents reduced PERG value 
analysis was detected, while the other patients 
(81.5%) had normal findings PERG. At the same 
time, this group, even though it held the lower 
amplitude values, showed no signs of damage to 
the visual field. Positive correlation in patients 
with glaucoma was found between the values of 
A and MD, while a significant negative correlation 
between the value of A and IOP, CPSD, stage of 
disease and the size of the excavation was 
confirmed. Similar correlation results were 
obtained in patients with ocular hypertension 
(confirmed by a positive correlation between the 
values of A and MD, while a negative correlation 
was confirmed between the values of A and the 
excavation and CPSD). The results obtained by 
the analysis of PERG in our study are consistent 
with previous studies (34,11), indicating the 
importance of damage to the retinal ganglion 
cells in the pathogenesis of the glaucoma 
disease. Correlation results in people with 
glaucoma are consistent with previous studies, 
which also showed a positive correlation with 
changes in the visual field (35-37). Similar to 
these findings, various studies using a similar 
methodology have shown that patients with 
glaucoma, in PERG amplitudes, show lower levels 
and are positively correlated with changes in the 
optic disc and visual field (28,38,39). Decrease in 
amplitude detected in some patients with ocular 
hypertension indicates that this person has a 
certain degree of retinal dysfunction but still 
without any detectable changes in the visual 
field, and that these changes are only detected 
by analyzing PERG. Bearing in mind that the 
results show that the number of such patients 
within the patients with ocular hypertension six 
months after the beginning of the test doubled, it 
can be assumed that the analysis of PERG is one 
of the reliable methods for early detection of pre-
perimetric glaucoma. Our results also confirmed 
previous studies that have shown the existence 
of PERG changes with no changes in the visual 
field in patients with ocular hypertension (34,40-
43) as well as in animal studies (17). It should be 
noted that changes in the PERG analysis in these 
patients do not necessarily determine the 
occurrence of glaucoma disease, as it is well 
known that only about 1% of those with ocular 
hypertension develop the glaucoma disease 
annually (44). Therefore, we need proper and 
precise separation of these patients, which would 
prevent unwanted effects of antiglaucoma 
therapy, particularly in patients in whom there is 
no possibility for the development of glaucoma.  
  In light of these results, the introduction of 
electrophysiological testing in everyday clinical 
practice for the early detection of glaucoma 
(diagnostic value) and in the monitoring of 
patients diagnosed with glaucoma (prognostic 
value) should be considered, with the aim of 
confirming the success of antiglaucomatous 
appropriate therapy in conjunction with other 
clinical diagnostic tests (7,14,19). 
  The test nowadays increasingly used for 
the functional state of ganglion cells is the 
multifocal electroretinogram (9). Simultaneous 
analyses of the local responses are recorded from 
different parts of the retina, allowing their fusion 
and reading the entire retinal responses. Therefore, 
nowadays, the use of this method allows precise 
localization of retinal dysfunction, long before any 
changes are detectable by perimetry allowing 
timely detection of pre-perimetric glaucoma and its 
prompt prevention (19,45). 
 
 Conclusion 
 
  Bearing in mind the results obtained in our 
study, particularly the values of the amplitude 
N95 PERG, we can assume that some electro-
physiological methods may represent a significant 
ancillary diagnostic method for prediction and 
early detection of glaucoma and the monitoring 
of disease in patients diagnosed with glaucoma. 
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POTENCIJALNA ULOGA VIZUELNO EVOCIRANIH POTENCIJALA I 
"PATTERN" ELEKTRORETINOGRAFIJE U DIJAGNOZI PRIMARNOG 
GLAUKOMA OTVORENOG UGLA 
 
Maja Petrović, Predrag Jovanović, Marija Trenkić Božinović, Lidija Bojović i Marina Jolić 
 
 
Glaukom predstavlja široko distribuiranu progresivnu optičku neuropatiju koja se 
karakteriše postepenim oštećenjem i gubitkom ganglijskih ćelija retine i očnog živca, 
povećanjem ekskavacije optičkog diska i obično, mada ne uvek, visokim  intra-
okularnim pritiskom, što na kraju rezultuje postepenim promenama u vidnom polju. U 
našoj studiji smo pokušali da utvrdimo potencijalnu ulogu i mesto elektrofizioloških 
ispitivanja (PERG i VEP) u ranom otkrivanju glaukomne optičke neuropatije, 
upoređivanjem elektrofizioloških parametara (P100 i A) i numeričkih oftalmoloških 
parametara kod ispitivanih bolesnika. Rezultati dobijeni u našoj studiji pokazuju da 
primena PERG metode otkriva rana oštećenja ganglijskih ćelija retine, dok iste 
promene nisu ustanovljene VEP analizom, ukazujući na potencijalnu prediktivnu ulogu 
PERG analize u ranoj dijagnostici preperimetrijskog glaukoma. Acta Medica Medianae 
2012;51(4):19-25. 
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